Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Alpha-Beta Technology discontinues phase III trial of Betafectin

Jan. 25, 1999

Cel-Sci and University of Maryland receive award for TB vaccine development

Jan. 22, 1999

Terprenin: novel immunosuppressant and antiallergic substance under evaluation at Shionogi

Jan. 22, 1999

Antex Biologics receives milestone payment from Pasteur Merieux Connaught

Jan. 21, 1999

FDA committee does not recommend approval of Prograf for GVHD

Jan. 21, 1999

Global FluMist collaboration announced by Aviron and Wyeth Lederle Vaccines

Jan. 14, 1999

Licensing opportunity from RCT: VZV subunit vaccine

Jan. 14, 1999

First vaccine for Lyme disease now available from SB in the U.S.

Jan. 13, 1999

Licensing opportunity from Peptech: anti-TNF antibodies with a range of therapeutic applications

Jan. 13, 1999

SangStat continues to progress with generic ciclosporin formulations

Jan. 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...